公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer | Ouyang X.; Liu Y.; Zhou Y.; Guo J.; TZU-TANG WEI ; Liu C.; Lee B.; Chen B.; Zhang A.; Casey K.M.; Wang L.; Kooreman N.G.; Habtezion A.; Engleman E.G.; Wu J.C. | Stem Cell Reports | 24 | 16 | |
2018 | Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo | Kooreman N.G.; Kim Y.; de Almeida P.E.; Termglinchan V.; Diecke S.; Shao N.-Y.; TZU-TANG WEI ; Yi H.; Dey D.; Nelakanti R.; Brouwer T.P.; Paik D.T.; Sagiv-Barfi I.; Han A.; Quax P.H.A.; Hamming J.F.; Levy R.; Davis M.M.; Wu J.C. | Cell Stem Cell | 101 | 85 | |
2022 | Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer | Luo C.-K.; Chou P.-H.; Ng S.-K.; Lin W.-Y.; TZU-TANG WEI | Cancer Gene Therapy | 13 | 11 | |
2017 | Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes | Lee W.H.; Chen W.-Y.; Shao N.-Y.; Xiao D.; Qin X.; Baker N.; Bae H.R.; TZU-TANG WEI ; Wang Y.; Shukla P.; Wu H.; Kodo K.; Ong S.-G.; Wu J.C. | Stem Cells | 50 | 42 | |
2019 | Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Oncotarget (2019) 10 (3577-3578) DOI: 10.18632/oncotarget.1628) | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; CHING-CHOW CHEN | Oncotarget | 0 | 0 | |
2017 | Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia (United States) 14 (2012) 463–475](S1476558612801023)(10.1596/neo.12300) | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chuang S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN | Neoplasia (United States) | 0 | 0 | |
2017 | Corrigendum to “Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer” (EBioMedicine Aug 2016; 10: 124–36) (S2352396416303243) (10.1016/j.ebiom.2016.07.019)) | TZU-TANG WEI | EBioMedicine | 0 | 0 | |
2012 | Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chung S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN | Neoplasia (United States) | 37 | 36 | |
2013 | Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase for cancer treatment | Chen, J.-B.; Chern, T.-R.; TZU-TANG WEI ; CHING-CHOW CHEN ; Lin, J.-H.; JIM-MIN FANG | Journal of Medicinal Chemistry | 62 | 62 | |
2016 | Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer | TZU-TANG WEI ; Lin, Yi-Ting; Chen, Wen-Shu; Luo, Ping; Lin, Yu-Chin; CHIA-TUNG SHUN ; Lin, Yi-Hsin; Chen, Jhih-Bin; Chen, Nai-Wei; Fang, Jim-Min; MING-SHIANG WU ; KAI-CHIEN YANG ; LI-CHUN CHANG ; Tai, Kang-Yu; JIN-TUNG LIANG ; CHING-CHOW CHEN | EBioMedicine | 31 | 29 | |
2021 | Fluorescent Nanohybrids from ZnS/CdSe Quantum Dots Functionalized with Triantennary, N-Hydroxy- p-(4-arylbutanamido)benzamide/Gallamide Dendrons That Act as Inhibitors of Histone Deacetylase for Lung Cancer | Chen C.-T.; Salunke S.; TZU-TANG WEI ; Tang Y.-A.; Wang Y.-C. | ACS Applied Bio Materials | 2 | 2 | |
2015 | Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer | TZU-TANG WEI ; Lin, Yu-Chin; Lin, Pei-Hua; JIN-YUAN SHIH ; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; CHING-CHOW CHEN | Oncotarget | 12 | 12 | |
2020 | Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer | TZU-TANG WEI ; Lin Y.-T.; Tang S.-P.; Luo C.-K.; Tsai C.-T.; CHIA-TUNG SHUN ; CHING-CHOW CHEN | Oncogene | 49 | 41 | |
2014 | Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; CHING-CHOW CHEN | Oncotarget | 45 | 41 | |
2015 | miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin | Chen W.-S.; Yen C.-J.; Chen Y.-J.; Chen J.-Y.; Wang L.-Y.; Chiu S.-J.; Shih W.-L.; Ho C.-Y.; TZU-TANG WEI ; Pan H.-L.; Chien P.-H.; Hung M.-C.; CHING-CHOW CHEN ; Huang W.-C. | Oncotarget | 34 | 32 | |
2012 | Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models | Shieh J.-M.; TZU-TANG WEI ; Tang Y.-A.; Huang S.-M.; Wen W.-L.; Chen M.-Y.; Cheng H.-C.; Salunke S.B.; Chen C.-S.; Lin P.; Chen C.-T.; Wang Y.-C. | PLoS ONE | 21 | 17 | |
2021 | A novel caffeic acid derivative prevents renal remodeling after ischemia/reperfusion injury | Huang C.-W.; Lee S.-Y.; TZU-TANG WEI ; Kuo Y.-H.; Wu S.-T.; Ku H.-C. | Biomedicine and Pharmacotherapy | 4 | 2 | |
2010 | A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer | Tang Y.-A.; Wen W.-L.; Chang J.-W.; TZU-TANG WEI ; Tan Y.-H.C.; Salunke S.; Chen C.-T.; Chen C.-S.; Wang Y.-C. | PLoS ONE | 48 | 44 | |
2016 | Prevention of colitis and colitis-associated colorectal cancer by a novel polypharmacological histone deacetylase inhibitor | TZU-TANG WEI ; Lin, Y.-T.; Tseng, R.-Y.; CHIA-TUNG SHUN ; Lin, Y.-C.; MING-SHIANG WU ; Fang, J.-M. ; CHING-CHOW CHEN | Clinical Cancer Research | 25 | 27 | |
2023 | The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses | Ng, Shang-Kok; Chung, Dai-Jung; LI-CHUN CHANG ; Luo, Cong-Kai; Jwo, Si-Han; Lee, Yau-Hsuan; JR-SHIUAN LIN ; Wang, Chun-Hao; TZU-TANG WEI | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 4 | | |